Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure

Fig. 3

Relationship between changes in β-hydroxybutyrate, blood pressure and vascular parameters. Correlation between changes (Δ) in β-hydroxybutyrate (β-OHB) between baseline and after 12 weeks of treatment with empagliflozin and changes in 24 h diastolic blood pressure (24 h DBP) (top left side), in forward pulse pressure height (FPH) (top right side) in central systolic blood pressure (cSBP) (bottom left side) and in central pulse pressure (cPP) (bottom right side) between baseline and after 12 weeks of treatment with empagliflozin

Back to article page